Thomas M. Riedhammer
Director/Board Member at Sirion Holdings, Inc.
Profile
Thomas M.
Riedhammer is currently a Director at Sirion Holdings, Inc. He was previously the Chairman at Sirion Therapeutics, Inc. and held director positions at Prevent Blindness Florida, National Society to Prevent Blindness, and Junior Achievement International.
He was also an Independent Director at Ohr Pharmaceutical, Inc. and a Director at DepYmed, Inc. In the past, he served as Senior Vice President & Chief Technical Officer at Bausch & Lomb, Inc., Corporate Vice President at Paco Pharmaceutical Services, Inc., and Chief Operating Officer at Presby Corp.
He was also the President of PACO Research Corp.
and Secretary at Sjögren's Syndrome Foundation, Inc. Riedhammer received his undergraduate and doctorate degrees from the State University of New York at Buffalo.
Thomas M. Riedhammer active positions
| Companies | Position | Start |
|---|---|---|
Sirion Holdings, Inc.
 Sirion Holdings, Inc. BiotechnologyHealth Technology Sirion Holdings, Inc. provides pharmaceutical products and medical devices for the ophthalmic market. It offers contract services, which includes clinical, regulatory, consulting, and medical education services. The company was founded by Susan K. Benton, Barry S. Butler, Philippe Boulangeat, and Vogel Roger in 2005 and is headquartered in Tampa, FL. | Director/Board Member | 2010-05-16 |
Former positions of Thomas M. Riedhammer
| Companies | Position | End |
|---|---|---|
Ohr Pharmaceutical, Inc.
 Ohr Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Ohr Pharmaceutical, Inc. engages in the development of novel therapeutics and delivery technologies for the treatment of ocular disease. Its product portfolio includes squalamine and SKS sustained release technology. The company was founded by Irach B. Taraporewala in 2008 and is headquartered in New York, NY. | Director/Board Member | 2019-07-11 |
Sirion Therapeutics, Inc.
 Sirion Therapeutics, Inc. BiotechnologyHealth Technology Sirion Therapeutics, Inc. provides biopharmaceutical products and services. It manufactures, develops and commercialize ophthalmic products for eye diseases. The company was founded by Barry Butler, Susan Benton, Philippe Boulangeat and Roger Vogel in November 2005 and is headquartered in Tampa, FL. | Chairman | - |
Bausch & Lomb, Inc.
 Bausch & Lomb, Inc. Medical SpecialtiesHealth Technology Bausch & Lomb, Inc. develops, manufactures, and markets eye health products. It offers over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care, ophthalmic surgical devices, and instruments. The company was founded by John Jacob Bausch and Henry Lomb in 1853 and is headquartered in Rochester, NY. | President | - |
| PACO Research Corp. | President | 1990-12-31 |
DepYmed, Inc.
 DepYmed, Inc. BiotechnologyHealth Technology DepYmed , Inc. is a cancer and rare disease therapeutic development company. The company is headquartered in Farmingdale, NY. | Director/Board Member | - |
Training of Thomas M. Riedhammer
| State University of New York at Buffalo | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 12 |
|---|---|
Bausch & Lomb, Inc.
Bausch & Lomb, Inc. Medical SpecialtiesHealth Technology Bausch & Lomb, Inc. develops, manufactures, and markets eye health products. It offers over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care, ophthalmic surgical devices, and instruments. The company was founded by John Jacob Bausch and Henry Lomb in 1853 and is headquartered in Rochester, NY. | Health Technology |
Paco Pharmaceutical Services, Inc.
 Paco Pharmaceutical Services, Inc. Miscellaneous ManufacturingProducer Manufacturing Part of West Pharmaceutical Services, Inc., Paco Pharmaceutical Services, Inc. is a private company that specializes in pharmaceutical packaging and preparation. The company is based in Lakewood, NJ. Paco Pharmaceutical Services was acquired by West Co., Inc. on April 28, 1995 for $54 million. | Producer Manufacturing |
Sirion Holdings, Inc.
Sirion Holdings, Inc. BiotechnologyHealth Technology Sirion Holdings, Inc. provides pharmaceutical products and medical devices for the ophthalmic market. It offers contract services, which includes clinical, regulatory, consulting, and medical education services. The company was founded by Susan K. Benton, Barry S. Butler, Philippe Boulangeat, and Vogel Roger in 2005 and is headquartered in Tampa, FL. | Health Technology |
Presby Corp
 Presby Corp Medical/Nursing ServicesHealth Services Part of Refocus Group, Inc., Presby Corp is a private company that researches and develops treatments for eye disorders. The company is based in Dallas, TX. Presby was acquired by Refocus Group, Inc. on March 06, 2003. | Health Services |
Sirion Therapeutics, Inc.
Sirion Therapeutics, Inc. BiotechnologyHealth Technology Sirion Therapeutics, Inc. provides biopharmaceutical products and services. It manufactures, develops and commercialize ophthalmic products for eye diseases. The company was founded by Barry Butler, Susan Benton, Philippe Boulangeat and Roger Vogel in November 2005 and is headquartered in Tampa, FL. | Health Technology |
National Society to Prevent Blindness
 National Society to Prevent Blindness Miscellaneous Commercial ServicesCommercial Services National Society to Prevent Blindness operates as an eye health and safety organization. It offers services for amblyopia, AMD, cataract, central retinal vein occlusion, colour blindness, conjunctivitis, diabetic eye disease and macular enema, dry eye, floaters, glaucoma, refractive eye, retinal tears and detachments, retinitis pigments and strabismus. The company was founded in 1908 and is headquartered in Chicago, IL. | Commercial Services |
| PACO Research Corp. | |
| Junior Achievement International | |
Ohr Pharmaceutical, Inc.
Ohr Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Ohr Pharmaceutical, Inc. engages in the development of novel therapeutics and delivery technologies for the treatment of ocular disease. Its product portfolio includes squalamine and SKS sustained release technology. The company was founded by Irach B. Taraporewala in 2008 and is headquartered in New York, NY. | Health Technology |
| Sjögren's Syndrome Foundation, Inc. | |
| Prevent Blindness Florida | |
DepYmed, Inc.
DepYmed, Inc. BiotechnologyHealth Technology DepYmed , Inc. is a cancer and rare disease therapeutic development company. The company is headquartered in Farmingdale, NY. | Health Technology |
- Stock Market
- Insiders
- Thomas M. Riedhammer